Sign Up

Home of Hepatology7 rue Daubin1203 GenevaSwitzerland+41 22 807 03 60easloffice@easloffice.eu© 2025 EASL. All rights reserved.Website by Soto.Privacy Policy | Cookie Policy | Terms & Conditions | Cyber Security Explore offerUnlock the full potential of being part of the EASLcommunity. As a member, you’ll gain access toexclusive resources, reduced event fees, top-tierjournals, and professional development opportunitiesdesigned to support your career in hepatologyBecome a memberNurses & Allied Health ProfessionalsLink titleYoung InvestigatorsLink titleBasic ScienceLink titleTitle here Lorem ipsum At the heart of EASL is a diverse and dynamic international community of professionals dedicated to advancing hepatology.Discover how you can get involved and make an impact.Whether you're a member, a Young Investigator, a nurse or allied health professional, or focused on basic science, there's a place for you here. Explore the different pathways to connect, grow and contribute, from membership benefits to tailored programmes and scientific networksLorem ipsum dolor sit ipsum CommunitySign In / Sign UpResourcesWhat We DoAbout Us Partnerships
Flyout Menu
Main Menu

Media

Press and media

EASL collaborates with a range of trusted media partners to amplify the reach of liver science and share the latest developments in hepatology with a wider audience. Through these partnerships, we promote EASL events, publications and initiatives, while supporting accurate, high-quality coverage of advances in liver research and care. If you are a media outlet interested in covering EASL activities or becoming a media partner, we invite you to get in touch with us.

Media

Our media partners

Visit the website
Visit the website
Visit the website
Visit the website
Visit the website
Visit the website
Visit the website
Visit the website

Press Releases

  • EASL News, Press Release

New breakthrough in advanced HCC

Digital Liver Cancer Summit 2021: New follow-up data from a landmark study of liver cancer patients treated with a combination of atezolizumab and bevacizumab has…
Read More
  • EASL News, Press Release

Global survey reveals heavy toll of COVID-19 first wave on liver cancer care

Digital Liver Cancer Summit 2021: A global survey assessing the impact of COVID-19 on liver cancer has revealed delays in the screening, diagnosis, and treatment…
Read More
  • EASL News, Press Release

On World Cancer Day, EASL warmly welcomes Europe’s Beating Cancer Plan

4 February 2021 The month of February brings together several key actions to tackle cancer globally, and EASL is focussing particularly on the global threat…
Read More
  • EASL News, Press Release

Liver community fights liver cancer with a robust action plan

Digital Liver Cancer Summit 2021: As the latest data suggests, liver cancer is now the third-most deadly cancer in the world, claiming nearly 1 million…
Read More
  • EASL News, Press Release

Significant improvements in mechanistic biomarkers of how Dialive™ improves organ function

About EASL and the ALIVER Consortium The ALIVER Consortium of 11 institutions from seven European countries developed an innovative liver dialysis machine called Dialive™. This…
Read More
  • EASL News, Press Release

Study identifies causes precipitating the most serious stage of cirrhosis

Researchers from EF Clif identify the causes that precipitate the onset of the most serious stage of cirrhosis: the syndrome of Acute-On-Chronic Liver Failure (ACLF)….
Read More
  • EASL News, Press Release

Muscle weakness and frailty adversely affect late-stage liver disease, study finds

AMRA Medical Research Results Support Strengthening Sarcopenia Guidelines AMRA Medical’s research publication in JHEP Reports details the link between MRI-based adverse muscle composition and NAFLD…
Read More
  • EASL News, Press Release

Autumn 2020 offers a crop of EASL hepatology fellowships

From ground-breaking discoveries to the Nobel Prize 2020, hepatology is cutting edge. This autumn, EASL has a crop of exciting fellowships on offer, to foster…
Read More
  • EASL News, Press Release

Hepatitis C scientists in the limelight: Nobel Prize 2020

5 October 2020 The Nobel Prize in Physiology or Medicine 2020 has been awarded jointly to Harvey J. Alter, Michael Houghton, and Charles M. Rice…
Read More
  • EASL News, Press Release

Patients with cirrhosis at increased risk of death from COVID-19, study finds

An international study led by researchers at Oxford University Hospitals NHS Foundation Trust has shown that patients with cirrhosis are at increased risk of dying…
Read More
Scroll to Top

Search EASL